MedPath

Evaluation of changes in urinary parameters after oral administration of magnesium chlorides and potassium citrate in pediatric with calcium oxalate urolithiasis.

Not Applicable
Conditions
urolithiasis.
Calculus of kidney and ureter
Registration Number
IRCT138707091282N1
Lead Sponsor
Isfahan University of Medical Sciences and Health Services
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
40
Inclusion Criteria

age 2-12 years with possibility of calcium oxalate kidney stone, No past history of peptic ulcer, chronic diarrhea or cardiac disease, primary hyperparathyroidism, consumption of anticonvulsants, No proven history of disorders affecting tubular ion excretion such as: recent urinary tract infection , distal renal tubular acidosis , chronic pyelonephritis, renal dysfunction and obstructive uropathy
Exclusion criteria: Patients who did not complete all steps of the study, refusing to consume either potassium citrate or magnesium chloride

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood parameter (Ca-K-Na-Cl-Cit-Ox-P-Cr-Mg). Timepoint: Before and 4 weeks after intervention. Method of measurement: blood test.;Urine parameter (Ca-K-Na-Cl-Cit-Ox-P-Cr-Mg). Timepoint: Before and4 weeks after intervention. Method of measurement: 24-hour urine test.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath